Douglas Crandell, Eric Furman, Ph.D. Drug development programs face unique challenges in demonstrating the safety and effectiveness of drugs for treating rare diseases. The FDA’s Accelerating Rare ...
Whereas cardiovascular disease-related mortality has declined in most developed countries, its known prevalence is increasing worldwide, although few data on the causes of heart disease in the ...
A new review study traces the complex links between biodiversity loss and emerging infectious diseases — though one doesn’t necessarily lead to the other. Instead, complex interactions between factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback